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Overall, the possibility of sparing the bowel at the cost of 
extra dose to the bladder and vice versa was demonstrated. 
The estimated change in primary tumor control for high 
versus low dose regimen was less than 1% for early stage 
tumors and approximately 5% for late stage tumors. 
 
 
 
 
 
Conclusion: There is room in the optimization space for 
incorporation of patient outcome and toxicity preferences. 
This opens for SDM for anal cancer patients. The study is to 
be expanded, with results for a total of 22 patients to be 
presented at ESTRO 2016. 
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Purpose or Objective: To explore the ability of quantitative 
prostate T2-weighted (T2-w) and apparent diffusion 
coefficient maps (ADC) MRI using Haralick texture features: i) 
to differentiate prostate cancer (PC) from healthy tissues; ii) 
to be correlated with Gleason score; iii) to predict 
biochemical recurrence after external beam radiotherapy 
(RT) for prostate cancer. 
 
Material and Methods: Tumor and prostate zones were 
segmented on co-registered T2-w and ADC on two pre-
treatment 3.0T MRI from 83 patients with a median age 67 
years (range 50-82 years) and a median pre-treatment PSA of 
9.8 ng/ml (range 3.4-48.0 ng/ml). 9 (11%) tumors were 
localized in the transitional zone (TZ) and 74 (89%) in the 
peripheral zone (PZ). Tumors were clinically staged as 
follows: 13% of T1, 46% of T2 and 41% of T3. Gleason scores 
were as follows: 6 (27%), 7 (51%), 8 (20%) and 9 (2%). They 
were 2% of low-risk, 33% of intermediate-risk and 65% of 
high-risk tumors according to D’Amico risk group 
classification. Almost all patients received standard 
treatment consisting in IMRT (100%) with IGRT (94%) 
associated with hormonal therapy in 53% of the patients. 
After a median follow-up of 47 months (range 19-65 months), 
11 patients had biochemical recurrence. A total of 114 grey-
leveled features (first order, gradient-based and second 
order Haralick texture characteristics) and 4 geometrical 
features (maximal tumor diameter, maximal tumor 
perimeter, maximal tumor area and tumor volume) were 
extracted on normalized T2-w and ADC and were analyzed. 
Statistical analyses were performed using Wilcoxon signed-
rank test, Spearman’s correlation coefficient, Harrell’s C-
index, Kaplan-Meier curves and univariate Cox regression 
analysis. 
 
Results: i) 56 out of 57 T2-w and 46 out of 57 ADC grey-
leveled features were significantly different between tumor 
and prostate tissues in the PZ and 25 out of 57 T2-w and 37 
out of 57 ADC features in the TZ (p<0.05). ii) 5 T2-w features 
and 4 ADC features were significantly correlated with 
Gleason score, all were Haralick texture features. iii) T2-w 
features that significantly predicted (p<0.05) biochemical 
recurrence were: maximal tumor 
diameter/perimeter/area/volume, Kirsch gradient operator, 
normalized mean and standard deviation of signal intensity 
and 8 Haralick texture features (Difference Variance, 
Contrast, Inverse Difference Moment, Difference Entropy, 
Information Measure of Correlation, Sum Average, Sum 
Variance and Sum of Squares). Only normalized mean value 
on ADC was significantly predictive of biochemical 
recurrence. 
 
Conclusion: Quantitative analysis using Haralick texture 
characteristics on T2-w MRI are good features: i) to 
differentiate prostate cancer from healthy tissues, ii) for 
Gleason score assessment and iii) to predict biochemical 
recurrence after RT. Geometrical characteristics extracted 
from T2-w are also good predictors of biochemical recurrence 
after RT. 
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Purpose or Objective: Tumour hypoxia is associated with 
poor response to radiotherapy. Comprehensive hypoxia 
assessment through [18F]-fluoromisonidazole (FMISO) PET 
imaging requires quantitative techniques, such as dynamic 
acquisition. However, dynamic FMISO PET protocols might be 
simplified by using DCE-MRI imaging in addition to static 
FMISO-PET. The aim of this work was to compare FMISO and 
DCE-MRI kinetic parameters by means of correlation analysis. 
 
Material and Methods: This study was done on N=6 head and 
neck cancer patients, who were imaged dynamically with 
FMISO-PET and DCE-MRI on the same day. Images were 
registered and analyzed for kinetics on a voxel basis. FMISO-
